Page 81 - Read Online

Page 16 of 17 Calinescu et al. Hepatoma Res 2021;7:59 https://dx.doi.org/10.20517/2394-5079.2021.26

Surg 2019;29:28-32. DOI PubMed
70. Perilongo G, Brown J, Shafford E, et al; Liver Tumour Study Group of the International Society of Paediatric Oncology (SIOP).
Hepatoblastoma presenting with lung metastases: Treatment results of the first cooperative, prospective study of the International
Society of Paediatric Oncology on childhood liver tumors. Cancer 2000;89:1845-53. DOI PubMed
71. Otte JB, Meyers R. PLUTO first report. Pediatr Transplant 2010;14:830-5. DOI PubMed
72. Kosola S, Lauronen J, Sairanen H, Heikinheimo M, Jalanko H, Pakarinen M. High survival rates after liver transplantation for
hepatoblastoma and hepatocellular carcinoma. Pediatr Transplant 2010;14:646-50. DOI PubMed
73. Browne M, Sher D, Grant D, et al. Survival after liver transplantation for hepatoblastoma: a 2-center experience. J Pediatr Surg
2008;43:1973-81. DOI PubMed
74. Khan AS, Brecklin B, Vachharajani N, et al. Liver Transplantation for malignant primary pediatric hepatic tumors. J Am Coll Surg
2017;225:103-13. DOI PubMed
75. Kim T, Kim DY, Kim KM, et al. Pediatric liver transplantation for hepatoblastoma: a single center experience. Transplant Proc
2012;44:523-5. DOI PubMed
76. Kasahara M, Ueda M, Haga H, et al. Living-donor liver transplantation for hepatoblastoma. Am J Transplant 2005;5:2229-35. DOI
PubMed
77. Angelico R, Grimaldi C, Gazia C, et al. How do synchronous lung metastases influence the surgical management of children with
hepatoblastoma? Cancers (Basel) 2019;11:1693. DOI PubMed PMC
78. Srinivasan P, McCall J, Pritchard J, et al. Orthotopic liver transplantation for unresectable hepatoblastoma. Transplantation
2002;74:652-5. DOI PubMed
79. Isono K, Ohya Y, Lee KJ, et al. Pretransplant trends in α-fetoprotein levels as a predictor of recurrence after living donor liver
transplantation for unresectable hepatoblastoma: a single-institution experience. Pediatr Transplant 2018;22:e13221. DOI PubMed
80. Lauferman L, Halac E, Aredes D, et al. Prognostic factors for event-free survival in liver transplantation for hepatoblastoma: a single-
center experience. Pediatr Transplant 2019;23:e13581. DOI PubMed
81. Czauderna P, Mackinlay G, Perilongo G, et al; Liver Tumors Study Group of the International Society of Pediatric Oncology.
Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J
Clin Oncol 2002;20:2798-804. DOI PubMed
82. D'Souza AM, Towbin AJ, Gupta A, et al. Clinical heterogeneity of pediatric hepatocellular carcinoma. Pediatr Blood Cancer
2020;67:e28307. DOI PubMed
83. Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma
beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009;10:35-43. DOI PubMed
84. Schmid I, von Schweinitz D. Pediatric hepatocellular carcinoma: challenges and solutions. J Hepatocell Carcinoma 2017;4:15-21.
DOI PubMed PMC
85. Sugawara Y. Living-donor liver transplantation for patients with hepatocellular carcinoma in Japan: current situations and challenge.
Hepatobiliary Pancreat Dis Int 2020;19:1-2. DOI PubMed
86. Ville de Goyet J, Meyers RL, Tiao GM, Morland B. Beyond the Milan criteria for liver transplantation in children with hepatic
tumours. Lancet Gastroenterol Hepatol 2017;2:456-62. DOI PubMed
87. Triana P, Dore M, Romo MM, et al. Hepatocellular carcinoma: referral to a transplantation unit. Eur J Pediatr Surg 2017;27:16-9.
DOI PubMed
88. Ismail H, Broniszczak D, Kaliciński P, et al. Liver transplantation in children with hepatocellular carcinoma. Do Milan criteria apply
to pediatric patients? Pediatr Transplant 2009;13:682-92. DOI PubMed
89. Ziogas IA, Benedetti DJ, Matsuoka LK, et al. Surgical management of pediatric hepatocellular carcinoma: an analysis of the National
Cancer Database. J Pediatr Surg 2021;56:772-7. DOI PubMed
90. Reyes JD, Carr B, Dvorchik I, et al. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in
childhood and adolescence. J Pediatr 2000;136:795-804. PubMed
91. Kelly D, Sharif K, Brown RM, Morland B. Hepatocellular carcinoma in children. Clin Liver Dis 2015;19:433-47. DOI PubMed
92. Ziogas IA, Ye F, Zhao Z, et al. Population-based analysis of hepatocellular carcinoma in children: identifying optimal surgical
treatment. J Am Coll Surg 2020;230:1035-44.e3. DOI PubMed
93. Baumann U, Adam R, Duvoux C, et al; European Liver and Intestine Transplant Association. Survival of children after liver
transplantation for hepatocellular carcinoma. Liver Transpl 2018;24:246-55. DOI PubMed
94. Ozçay F, Canan O, Bilezikçi B, Torgay A, Karakayali H, Haberal M. Effect of living donor liver transplantation on outcome of
children with inherited liver disease and hepatocellular carcinoma. Clin Transplant 2006;20:776-82. DOI PubMed
95. Llovet JM, Ricci S, Mazzaferro V, et al; SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl
J Med 2008;359:378-90. DOI PubMed
96. Liang W, Wu L, Ling X, et al. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular
carcinoma: a meta-analysis. Liver Transpl 2012;18:1226-36. DOI PubMed
97. Katz SC, Shia J, Liau KH, et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular
carcinoma. Ann Surg 2009;249:617-23. DOI PubMed
98. Nishizaki T, Matsumata T, Kanematsu T, Yasunaga C, Sugimachi K. Surgical manipulation of VX2 carcinoma in the rabbit liver
evokes enhancement of metastasis. J Surg Res 1990;49:92-7. DOI PubMed
99. Beaunoyer M, Vanatta JM, Ogihara M, et al. Outcomes of transplantation in children with primary hepatic malignancy. Pediatr
Transplant 2007;11:655-60. DOI PubMed